Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
06/2010
06/03/2010US20100137188 Formulations comprising cyclic compounds
06/03/2010US20100136684 Natural IgM Antibodies
06/03/2010US20100136590 Method of Determining NT-proBNP
06/03/2010US20100136580 Disheveled pdz modulators
06/03/2010US20100136539 Ezrin assay method for the in vitro diagnosis of colorectal cancer
06/03/2010US20100136535 Means and methods for detecting protein-peptide interactions
06/03/2010US20100136527 Dominant B Cell Epitopes and Methods of Making and Using Thereof
06/03/2010US20100136519 Determination of a specific immunoglobulin using multiple antigens
06/03/2010US20100136211 IFBM's to Promote the Specific Attachment of Target Analytes to the Surface of Orthopedic Implants
06/03/2010US20100136098 Avian influenza vaccine
06/03/2010US20100136039 Borrelia antigens
06/03/2010US20100136034 Novel multimeric molecules, a process for preparing the same and the use thereof for manufacturing medicinal drugs
06/03/2010US20100136014 GIPs, a Family of Polypeptides with Transcription Factor Activity that Interact with Goodpasture Antigen Binding Protein
06/03/2010US20100135975 CD133 Epitopes
06/03/2010US20100135955 HUMAN M2e PEPTIDE IMMUNOGENS
06/03/2010US20100135948 Anti-Autoimmune Antibodies for Treatment of Pemphigus
06/03/2010US20100135941 Skin-whitening agent
06/03/2010CA2744787A1 Compositions and methods for treatment of celiac disease
06/03/2010CA2743986A1 A nonapeptide with anti-tumour activity
06/02/2010EP2192407A2 Method of detecting cellular immunity and application thereof to drugs
06/02/2010EP2192192A1 Kinase and phosphatase assays
06/02/2010EP2192179A1 Cdh3 peptide and medicinal agent comprising the same
06/02/2010EP2192131A1 Immunoglobulins devoid of light chains
06/02/2010EP2192129A1 Metalloprotease activation of myostatin, and methods of modulating myostatin activity
06/02/2010EP2190860A1 Blood coagulation factor inhibitors
06/02/2010EP2190859A1 Genes and proteins for the biosynthesis of the lantibiotic 107891
06/02/2010EP2190451A1 Treatment of atherosclerosis
06/02/2010EP1481000B1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
06/02/2010EP1306005B1 Nonhuman animal models non-responsive to mycoplasma-origin lipoprotein/lipopeptide
06/02/2010CN1354755B Nucleotide and protein sequence of Nogo genes and methods based thereon
06/02/2010CN1291231B Human telomerase catalytic subunit
06/02/2010CN101270154B Cyclo-pentapeptide with antineoplastic activity
06/02/2010CN101186644B H3 type flu virus hemagglutinin space conformation simulation antigen epitope and application thereof
06/01/2010US7728127 Cross-linked glycopeptide-cephalosporin antibiotics
06/01/2010US7728121 Nucleotide sequences coding portion of viral early gene; generating immunoglobulin for detecting viral infection
06/01/2010US7728111 Anti-p55 TNF receptor antibody
06/01/2010US7727960 Neutropenia; treating autoimmune diseases, acute inflammatory diseases, trauma, local inflammations, shock and burn
06/01/2010US7727956 Deoxonadepsipeptides
06/01/2010US7727950 Methods and reagents for assaying protein kinase activity
06/01/2010US7727752 Using mixture of peptide and detectable compound; adjust proteolytic sensitivity; protein translational activity
06/01/2010US7727739 Methods for measuring enzyme activity
06/01/2010CA2442679C Methods for secretory production of proteins
06/01/2010CA2376025C Echinocandin derivatives, method for preparing same and application as antifungal agents
06/01/2010CA2115839C Hla-restricted hepatitis b virus ctl epitopes
05/2010
05/27/2010WO2010059051A2 Rapid fret based pathogen diagnosis
05/27/2010WO2010058427A2 Process for production and purification of polymyxin b sulfate
05/27/2010WO2010057882A2 Composition for producing anti-amyloid beta peptide antibodies with d-peptides
05/27/2010WO2010057275A1 Cyclic peptides and uses thereof
05/27/2010WO2010057251A1 Peptide conjugates for suppressing an immune response, methods of making and uses therefor
05/27/2010WO2010057242A2 Vaccine
05/27/2010WO2010028096A3 Peptides presenting an epitope of an a domain of factor h binding protein
05/27/2010WO2010000591A3 Fluorescent cyclic peptides, methods for the preparation thereof, and use of said peptides for measuring the enzymatic activity of a protease enzyme
05/27/2010WO2009148252A3 Stroke-targeting peptide and use thereof
05/27/2010US20100130722 Polymeric carrier for delivery of small interfering rna
05/27/2010US20100130433 Casein-Derived Peptides having Anxiolytic Activity
05/27/2010US20100130432 Non-Natural Amino Acids and Neurotensin Analogues Thereof
05/27/2010US20100130430 Stabilized therapeutic small helical antiviral peptides
05/27/2010US20100130416 Modulation of angiogenesis by a-beta peptide fragments
05/27/2010US20100130411 Method for treating cartilage disorders
05/27/2010US20100130410 Neural regeneration peptides and methods for their use
05/27/2010US20100130408 Use of modified cyclosporins
05/27/2010US20100129927 Peptides for Use in Diagnosing the Presence of Ruptured Atherosclerotic Lesions in a Individual
05/27/2010US20100129390 Dkk1 as a universal tumor vaccine for immunotherapy of cancers
05/27/2010US20100129374 Mammalian Cell Membrane Proteins; Related Reagents
05/27/2010US20100129344 Medical uses and therapies based upon the action of azurocidin on igfbp-1
05/27/2010US20100129289 Compositions and methods for the detection of vulnerable plaque
05/27/2010CA2743950A1 Peptide conjugates for suppressing an immune response, methods of making and uses therefor
05/27/2010CA2743172A1 Crystalline form of linaclotide
05/26/2010EP2189536A1 Rapid FRET based anthrax diagnosis
05/26/2010EP2189472A1 Lantibiotic biosynthetic gene clusters from A. garbadinensis and A. liguriae
05/26/2010EP2189471A1 Foxm1 peptide and medicinal agent comprising the same
05/26/2010EP2189470A1 Tumor antigens
05/26/2010EP2188304A1 Detection and quantitation of urine gelsolin
05/26/2010EP1572168B1 Anti-infarction molecules
05/26/2010EP1448602B1 Modified anti-tnf alpha antibody
05/26/2010CN1829735B Imaging agents
05/26/2010CN1756763B Dimerized peptide
05/26/2010CN1711279B Epstein Barr virus peptide epitopes, polyepitopes and delivery system therefor
05/26/2010CN101715340A suspension formulations of insulinotropic peptides and uses thereof
05/26/2010CN101712716A Method for preparing vapreotide
05/26/2010CN101143895B Polypeptide with tumour targeting effects and preparation method thereof
05/25/2010US7723499 polynucleotides that code for polypeptides comprising amino acid sequences that preferentially recognize and bind to angiopoietins
05/25/2010US7723477 Frizzled receptor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
05/25/2010US7723470 Antibiotic of given structure; vancomycin derivatives; enhanced activity, selectivity and reduced mammalian toxicity
05/25/2010US7723469 Treating leukemia by administering a cross-linked polypeptide antiapoptosis agent having at least two modified amino acids ("hydrocarbon stapling"); crosslinking increases cell permeability
05/25/2010US7723468 Antimicrobial peptide, compositions, and uses therefor
05/25/2010US7723467 Antimicrobial compounds
05/25/2010US7723303 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
05/25/2010US7723295 Peptides and compounds that bind to a receptor
05/25/2010CA2248243C Purification of tissue plasminogen activator (tpa)
05/20/2010WO2010055929A1 Novel hsp90-targeted anti-cancer chimeric peptide
05/20/2010WO2010055711A1 Peptide composition for saving the life of sirs patient
05/20/2010WO2010055500A1 A vaccinia virus protein a46 peptide and use thereof
05/20/2010WO2010055343A1 Degradable supports for tide synthesis
05/20/2010WO2010055135A1 Process for the purification of human growth hormone polypeptides using affinity resins comprising specific ligands
05/20/2010WO2010035107A3 Peptides and compositions for prevention of cell adhesion and methods of using same
05/20/2010WO2009083663A8 Cyclic peptides comprising at least one aza-β3-aminoacyl residue and uses thereof
05/20/2010US20100125127 Activation antigen expressed on B-cells for treating conditions associated with aberrant or increased T-cell proliferation
05/20/2010US20100125056 Crystalline form of linaclotide
05/20/2010CA2744120A1 A vaccinia virus protein a46 peptide and use thereof
1 ... 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 ... 423